Business
The digital cardiology platform is designed to give patients a comprehensive, equitable and accessible way to manage hypertension and heart disease.
The SEC has charged uBiome cofounders with defrauding investors and pushing doctors to order unnecessary medical tests.
This Series B round brings the company's total funding to $223.5 million.
The round was led by Insight Partners Spark Capital, Concord Health Partners and HWVP with participation from KKR, Rivas Capital and Sigmas Group.
Scale Venture Partners and Insight Partners led the financing with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures.
The startup's platform now covers more than 20 million lives and is available worldwide.
The Palo Alto startup said that 2020 was its strongest year to date.
The company is now valued at more than $1.6 billion.
Grand Rounds' CEO Owen Tripp will continue on as the CEO of the combined entity.
The funding will go towards expanding mental health provision for post-pandemic Britain.